Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis, Scleroderma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03444220
What this trial is testing

Gut Microbiota Transplantation in Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
Oslo University Hospital 10
Not applicableUnknownNCT05351060
What this trial is testing

Novel Splinting Technique Using 3D Models

Who this might be right for
ArthritisOsteoarthritis HandScleroderma, Systemic+2 more
Giovanna Fichera 10
Not applicableLooking for participantsNCT07491523
What this trial is testing

Double Immunosuppression With or Without Anti-fibrotic in Scleroderma ILD

Who this might be right for
SSc-Systemic Sclerosis
University of Patras 35
Not applicableStudy completedNCT03092024
What this trial is testing

Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility Study

Who this might be right for
SclerodermaSystemic Sclerosis
Lady Davis Institute 40
Not applicableUnknownNCT04319120
What this trial is testing

Pilot Study of Description of Cicatrisation Rates of Digital Ulcers in Systemic Scleroderma

Who this might be right for
Scleroderma, Systemic
University Hospital, Limoges 78
Not applicableEnrolling By InvitationNCT06472362
What this trial is testing

Chest CT Biomarkers as Prognostic Predictors in SSc-ILD

Who this might be right for
Systemic Sclerosis
Royal Brompton & Harefield NHS Foundation Trust 1,000
Not applicableStudy completedNCT04484948
What this trial is testing

Utility of Breath-holding Test in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Seoul National University Hospital 120
Testing effectiveness (Phase 2)WithdrawnNCT04138485
What this trial is testing

Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
CSL Behring
Not applicableUnknownNCT05450276
What this trial is testing

Patient-Reported Outcome Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 56
Testing effectiveness (Phase 2)Study completedNCT03274076
What this trial is testing

Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Who this might be right for
Systemic SclerosisScleroderma
University of Michigan 15
Very early researchNot Yet RecruitingNCT07674147
What this trial is testing

RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases

Who this might be right for
Autoimmune DiseasesSLE - Systemic Lupus ErythematosusSSc-Systemic Sclerosis+3 more
The Children's Hospital of Zhejiang University School of Medicine 30
Not applicableLooking for participantsNCT07345052
What this trial is testing

Western Sweden Systemic Sclerosis Project

Who this might be right for
Scleroderma, SystemicFibrosis; SkinFibrosis Lung+1 more
Sahlgrenska University Hospital 150
Not applicableLooking for participantsNCT07515638
What this trial is testing

Immun4Cure Cohort of Autoimmune Diseases

Who this might be right for
Rheumatoid ArthritisSystemic Lupus ErythematosusSystemic Sclerosis+1 more
University Hospital, Montpellier 500
Testing effectiveness (Phase 2)Looking for participantsNCT05892614
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Who this might be right for
Interstitial Lung Disease
aTyr Pharma, Inc. 25
Testing effectiveness (Phase 2)UnknownNCT00573326
What this trial is testing

Low-Dose Oral Imatinib for Scleroderma Pulmonary Involvement

Who this might be right for
Systemic Sclerosis
Azienda Ospedaliera Universitaria Policlinico 30
Testing effectiveness (Phase 2)Study completedNCT02228850
What this trial is testing

Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) 35
Not applicableUnknownNCT05007340
What this trial is testing

ILD-SARDs Registry and Biorepository

Who this might be right for
Interstitial Lung DiseaseSystemic Autoimmune DiseaseRheumatic Diseases+6 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 252
Not applicableWithdrawnNCT03937271
What this trial is testing

Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome

Who this might be right for
Sjögren's SyndromeSystemic Lupus ErythematosusRheumatoid Arthritis+3 more
Taipei Veterans General Hospital, Taiwan
Not applicableStudy completedNCT05533034
What this trial is testing

Personalized Home Respiratory Rehabilitation Program for Subjects With Systemic Sclerosis With Early Lung Disease

Who this might be right for
Systemic Sclerosis
Assistance Publique - Hôpitaux de Paris 15
Not applicableUnknownNCT05204784
What this trial is testing

Rheopheresis for Raynaud's and Digital Ulcers in Systemic Sclerosis

Who this might be right for
Systemic SclerosisRaynaud PhenomenonDigital Ulcer+1 more
Peter Korsten 30
Next Page